J Korean Soc Transplant.  2010 Jun;24(2):69-72. 10.4285/jkstn.2010.24.2.69.

Transplantation Options in Type 1 Diabetes with End Stage Renal Disease

• Kim JH

• KMID: 1457121
• DOI: http://doi.org/10.4285/jkstn.2010.24.2.69

Abstract

For patients with type 1 diabetes complicated by end stage renal disease (ESRD), kidney transplantation prolongs life and frees the recipient from the substantial morbidities of dialysis. Transplantation of whole pancreas has emerged as an effective treatment modality for patients with diabetes mellitus, especially those with established end-stage renal disease. However, it is not clear that transplantation of the pancreas itself prolongs the life of the recipient. Living donor kidney transplant (LDKT) and simultaneous pancreas-kidney transplant (SPKT) provide distinct benefits over deceased donor kidney transplant (DDKT) alone. But, previous studies have not demonstrated that the SPKT approach prolongs life compared with LDKT. Patients who receive an LDKT can later opt for a pancreas after kidney transplant (PAKT) or an islet after kidney transplant (IAKT). Therefore, when a transplant doctor is counseling a patient with type 1 diabetes and ESRD and has a live donor, the decision about whether to proceed with an LDKT or to remain on the waiting list for an SPKT requires careful consideration. The aim of this review was to summarize the current status and outcomes of SPKT, LDKT, IAKT, and PAKT and their effects on survival of patients with type 1 diabetes and ESRD.

Keyword

Type 1 diabetes mellitus; End stage renal disease (ESRD); Islet cell transplantation; Pancreas transplantation; Kidney transplantation

MeSH Terms

Counseling
Diabetes Mellitus
Diabetes Mellitus, Type 1
Dialysis
Humans
Kidney
Kidney Failure, Chronic
Kidney Transplantation
Living Donors
Pancreas
Pancreas Transplantation
Tissue Donors
Transplants
Waiting Lists

Reference

References

1). Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999; 341:1725–30.

2). Meier-Kriesche HU, Ojo AO, Port FK, Arndorfer JA, Cibrik DM, Kaplan B. Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol. 2001; 12:1293–6.

3). Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA. 2003; 290:2817–23.

4). Gruessner RW, Sutherland DE, Gruessner AC. Mortality assessment for pancreas transplants. Am J Transplant. 2004; 4:2018–26.

5). White SA, Shaw JA, Sutherland DE. Pancreas transplantation. Lancet. 2009; 373:1808–17.

6). Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman A, Magee JC, Cibrik D, et al. The impact of simultaneous pancreas-kidney transplantation on longterm patient survival. Transplantation. 2001; 71:82–90.

7). Reddy KS, Stablein D, Taranto S, Stratta RJ, Johnston TD, Waid TH, et al. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis. 2003; 41:464–70.

8). Waki K, Terasaki PI. Kidney graft and patient survival with and without a simultaneous pancreas utilizing contralateral kidneys from the same donor. Diabetes Care. 2006; 29:1670–2.

9). Young BY, Gill J, Huang E, Takemoto SK, Anastasi B, Shah T, et al. Living donor kidney versus simultaneous pancreas-kidney transplant in type 1 diabetics: an analysis of the OPTN/UNOS database. Clin J Am Soc Nephrol. 2009; 4:845–52.

10). Gaston RS, Basadonna G, Cosio FG, Davis CL, Kasiske BL, Larsen J, et al. Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report. Am J Kidney Dis. 2004; 44:529–42.

11). Kim JH, Lee MK, Islet transplantation vs. pancreas transplantation. Hanyang Med Rev. 2009; 29:186–191. (김재현, 이문규, 췌도이식과 췌장이식, 한양의대학술지 2009;29: 186–91.).

12). Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005; 54:2060–9.

13). Kim JH, Kim KW. History, current status and perspective of islet transplantation. Korean J Med. 2008; 75:274–9. (김재현, 김광원. 췌도이식의 과거, 현재 및 미래. 대한내과학회지 2008;75: 274–9.).

14). Gerber PA, Pavlicek V, Demartines N, Zuellig R, Pfammatter T, Wüthrich R, et al. Simultaneous islet-kidney vs pancreas-kidney transplantation in type 1 diabetes mellitus: a 5 year single centre follow-up. Diabetologia. 2008; 51:110–9.

15). Lehmann R, Spinas GA, Moritz W, Weber M. Has time come for new goals in human islet transplantation? Am J Transplant. 2008; 8:1096–100.